Skip to content
Screener

Gain Therapeutics GANX Q4 2025 Annual earnings

Reported March 26, 2026 · Before market open

EPS-$0.11Beat by $0.03
Revenue estimate$25.0K
EPS estimate-$0.14

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$33.3K
EPS estimate-$0.13

FAQ

When did Gain Therapeutics report Q4 2025 earnings?
Gain Therapeutics (GANX) reported Q4 2025 earnings on March 26, 2026 before market open.
What were Gain Therapeutics's Q4 2025 revenue and EPS?
Gain Therapeutics reported eps of $-0.11 for Q4 2025.
Did Gain Therapeutics beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.14 by $0.03.
How did Gain Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 0.0% from $-0.11.
Where can I find Gain Therapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-035174) and the 10-K periodic report (0001104659-26-035188) directly on SEC EDGAR. The filing index links above go to sec.gov.